Doctor profile · Federal record
Dr. David Harnick, M.D.
Cardiovascular Disease Physician (CMS: Cardiac Electrophysiology) · New York, NY
- NPI 1942212642
- MIPS 0.0 / 100 · 2023
- 30 yrs in practice
- Male
- Solo practice
- No sanctions
Practice & contact
Operates at 2 locations .
- Primary practice
-
148 E 38Th St
New York, NY 100162607
(212) 679-4488
fax (212) 684-4841 - Additional location
-
35 E 85Th St Ofc 2
New York, NY 100280962
(212) 988-3772
fax (212) 861-4672
Credentials & registration
- NPI registered
- August 2006 — 20 yrs on file
- Profile last updated
- March 6, 2023
- Year of graduation
- 1996 — 30 yrs since
- Specialty taxonomy
- 207RC0000X — NUCC code
- State license (1)
- New York #207256
- Medicaid
- NY #02432933
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1942212642. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
9,714
Distinct HCPCS
10
Medicare allowed
$890,450
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
G2066 |
Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | 1,781 | 250 | $81 | |
93298 |
Evaluation of cardiac rhythm monitor system, remote up to 30 days | 1,363 | 200 | $28 | |
99458 |
Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes | 807 | 61 | $43 | |
99490 |
Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | 529 | 86 | $66 | |
99457 |
Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | 525 | 64 | $53 | |
93297 |
Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | 423 | 59 | $28 | |
99454 |
Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | 420 | 60 | $57 | |
93000 |
Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 395 | 258 | $16 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 380 | 260 | $99 | |
93294 |
Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 364 | 129 | $32 |
In context: peer comparison
Among 234 peers in this city , average services per provider: 176. This provider delivers 55× the peer median.Open Payments
Industry payments received
All-time total
$7,511
Transactions
87
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| SANOFI-AVENTIS U.S. LLC | 4 | $5,212.63 | |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 12 | $362.66 | |
| Lilly USA, LLC | 6 | $240.71 | |
| Boston Scientific Corporation | 3 | $203.38 | |
| AstraZeneca Pharmaceuticals LP | 11 | $203.14 | |
| Janssen Pharmaceuticals, Inc | 7 | $201.48 | |
| Esperion Therapeutics, Inc. | 10 | $196.34 | |
| Lexicon Pharmaceuticals, Inc. | 14 | $195.92 | |
| Medtronic, Inc. | 2 | $174.89 | |
| Merck Sharp & Dohme LLC | 6 | $147.10 | |
| Novartis Pharmaceuticals Corporation | 5 | $101.08 | |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $82.65 | |
| Actelion Pharmaceuticals US, Inc. | 2 | $55.00 | |
| Kowa Pharmaceuticals America, Inc. | 1 | $50.25 | |
| E.R. Squibb & Sons, L.L.C. | 1 | $34.67 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
1,720
Patients
475
Total drug cost
$623,988
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Eliquis (Apixaban) | Brand | 342 | 70 | $346,763 |
| Metoprolol Succinate | Generic | 292 | 84 | $7,187 |
| Losartan Potassium | Generic | 142 | 44 | $2,244 |
| Amlodipine Besylate | Generic | 131 | 37 | $1,236 |
| Rosuvastatin Calcium | Generic | 128 | 39 | $2,809 |
| Furosemide | Generic | 112 | 35 | $757 |
| Atorvastatin Calcium | Generic | 98 | 32 | $1,854 |
| Atenolol | Generic | 87 | 24 | $1,222 |
| Entresto (Sacubitril/Valsartan) | Brand | 75 | 19 | $84,404 |
| Xarelto (Rivaroxaban) | Brand | 67 | 20 | $75,336 |
Hospital affiliations
Frequently asked questions
What is Dr. David Harnick's medical specialty?
Dr. David Harnick practices Cardiovascular Disease Physician in New York, NY.
Where does Dr. David Harnick practice?
Dr. David Harnick practices at 148 E 38Th St, New York, NY 100162607. Office phone: 2126794488.
What is Dr. David Harnick's NPI?
Dr. David Harnick's National Provider Identifier (NPI) is 1942212642, issued by NPPES.
Does Dr. David Harnick accept Medicare assignment?
Dr. David Harnick does not accept Medicare assignment for all services. Patients may be billed amounts beyond Medicare-allowed charges.
What procedures does Dr. David Harnick commonly perform?
Top Medicare-reported procedures in 2023: Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec (HCPCS G2066); Evaluation of cardiac rhythm monitor system, remote up to 30 days (HCPCS 93298); Management using the results of remote vital sign monitoring per calendar month (HCPCS 99458). Source: CMS Medicare Physician & Other Practitioners file.